UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000055617
Receipt number	R000063543
Scientific Title	Observational study for conversion rate to surgery in the patients who are planned to be treated with Durvalumab with Gemcitabine plus Cisplatin due to unresectable biliary tract cancers by locally advance or oligo-metastasis (GC-D conversion study) CSGO-HBP024
Date of disclosure of the study information	2024/09/25
Last modified on	2024/09/25 16:56:55

---